AVGO arrives at its June 3 earnings report on the back of a sharp re-rating, with the Street broadly aligned behind further upside — and almost no short-side pressure to complicate the picture.
The price momentum since the previous note is striking. From $422 a week ago, Broadcom has pushed to $446.77 — a gain of nearly 8% on the week and 12% over the past month. That rally has run ahead of the analyst consensus: the mean price target now sits at $482, implying roughly 8% upside from current levels, though targets range as high as $545 from Wells Fargo. The lending market confirms there is no meaningful short camp. Borrow availability is entirely unconstrained — the pool is effectively open — and cost to borrow has settled at just 0.28%, having briefly spiked mid-week before retreating. Short interest is 1.1% of free float, down about 4% on the week. This is a stock without a short thesis.
Options positioning tells a similarly calm story. The put/call ratio is running at 1.14, essentially in line with its 20-day average of 1.14 and barely a fraction of a standard deviation below it. That places the ratio in the mid-range of its 52-week band (0.89–1.23). Heading into a closely watched print, this is steady rather than hedged — options traders are not paying a premium to protect against a downside surprise.
The analyst community has been emphatic in the run-up. Multiple firms lifted targets in May: Wells Fargo moved to $545 from $430, TD Cowen to $500 from $405, and UBS and Citigroup both raised to $490–$500. The direction of travel is unanimous — no downgrades, no holds turning negative. The bull case centres on AI infrastructure demand, Broadcom's custom accelerator relationships with hyperscalers including Google, and the resilience of its infrastructure software segment. Bears point to semiconductor cyclicality, trade-war exposure, and the question of whether AI spending sustains at current levels or hits an air pocket. The ORTEX stock score of 78.6 leans toward the bulls, with quality (84.7) and 90-day EPS momentum (73rd percentile) as the strongest pillars. Valuation is the weak point — a PE of 31x and EV/EBITDA of 24.8x leave limited room for a miss.
Insider activity leans net-positive over 90 days in aggregate, though the recent pattern is one of selling. Chairman Henry Samueli disposed of roughly $66 million in late March, and two divisional presidents sold in early April near $345–$370. Those sales came during the stock's trough — the stock has since rallied 25% from those levels — making them appear opportunistic rather than bearish on fundamentals. Peer performance adds context: CRDO surged 22% on the week, and MRVL gained 7.5%, both correlated names riding the same AI infrastructure tailwind. Broadcom's 8% move is notable but not an outlier in the group.
The June 3 print is therefore less about whether AI demand is real and more about whether Broadcom can quantify its custom ASIC pipeline — and whether guidance for the back half of the year justifies a stock now trading back near the upper end of the analyst target range.
See the live data behind this article on ORTEX.
Open AVGO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
AVGO enters the final stretch before its June 3 earnings with a modest pullback from recent highs, a cost-to-borrow spike worth watching, and options traders showing just a touch more caution than last week. The price…
AVGO heads into its June 3 earnings with a clean short-interest picture, a fresh analyst target raise from Citigroup, and insider selling from the spring that now looks like routine plan activity rather than a warning…
